---
title: "ResMed Earnings Report: Q2 Overview"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/274203068.md"
description: "ResMed (NYSE:RMD) reported its Q2 earnings on January 29, 2026, beating estimates by 4% with an EPS of $2.81 compared to the expected $2.71. Revenue increased by $140.81 million year-over-year. In the previous quarter, ResMed also exceeded EPS estimates but experienced a 2% drop in share price the following day. Historical performance shows consistent growth in EPS and revenue over the past quarters. For more details, visit ResMed's earnings calendar."
datetime: "2026-01-29T21:12:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274203068.md)
  - [en](https://longbridge.com/en/news/274203068.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274203068.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274203068.md) | [English](https://longbridge.com/en/news/274203068.md)


# ResMed Earnings Report: Q2 Overview

**ResMed** (NYSE:RMD) just disclosed its Q2 earnings on Thursday, January 29, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

### Earnings

ResMed beat estimated earnings by 4.0%, reporting an EPS of $2.81 versus an estimate of $2.71.

Revenue was up $140.81 million from the same period last year.

### Previous Earnings Records

Last quarter the company beat on EPS by $0.05 which was followed by a 2.0% drop in the share price the next day.

Here's a look at ResMed's past performance:

**Quarter**

**Q1 2026**

**Q4 2025**

**Q3 2025**

**Q2 2025**

**EPS Estimate**

2.50

2.47

2.36

2.31

**EPS Actual**

2.55

2.55

2.37

2.43

**Revenue Estimate**

1.33B

1.33B

1.28B

1.27B

**Revenue Actual**

1.34B

1.35B

1.29B

1.28B

To track all earnings releases for ResMed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### 相關股票

- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [Resmed (RMD.US)](https://longbridge.com/zh-HK/quote/RMD.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)

## 相關資訊與研究

- [ResMed Earnings Preview: What to Expect](https://longbridge.com/zh-HK/news/281019552.md)
- [AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS](https://longbridge.com/zh-HK/news/281548288.md)
- [Electra Battery Materials GAAP EPS of -C$4.16](https://longbridge.com/zh-HK/news/280982421.md)
- [Here's What to Expect From Freeport-McMoRan’s Next Earnings Report](https://longbridge.com/zh-HK/news/281163913.md)
- [Raymond James Financial Earnings Preview: What to Expect](https://longbridge.com/zh-HK/news/281024632.md)